Poustchi H, Majd Jabbari S, Merat S, Sharifi AH, et al. The combination of sofosbuvir and daclatasvir is effective and safe in treating patients with hepatitis C and severe renal impairment. J Gastroenterol Hepatol 2020;35:1590-1594.
PMID: 31994788